Based on the latest recommendation, the company anticipates receiving marketing authorisation for the system in the first ...

A new drug therapy for aggressive advanced breast cancer could potentially double the amount of time patients live without ...

The accelerated approval of Trodelvy for patients with metastatic urothelial cancer has been voluntarily withdrawn.

A three-drug therapy targeting breast cancer could double the amount of time patients live without the disease progressing, a trial has found. Researchers praised the “huge breakthrough” as ...

(RTTNews) - IceCure Medical Ltd. (ICCM), Friday announced that the U.S. Food and Drug Administration's Advisory panel has voted in favor of the company's ProSense technology intended for early-stage ...

The FDA continues to approve new drugs and expand indications for others at a rapid pace. Here’s a summary of what happened ...

IceCure Medical Ltd., a developer of minimally-invasive cryoablation technology that destroys tumours by freezing as an alternative to surgical tumour removal, announced the US Food and Drug ... stage ...

MI Cancer Seek has received approval from the FDA as a companion diagnostic test to identify those who may benefit from ...

Palazestrant has been granted U.S. Food and Drug Administration (FDA) Fast Track designation for the treatment of ER+/HER2- metastatic breast cancer that has progressed following one or more lines of ...

Now you can get a tax deduction or reimbursement for certain medical expenses, like over-the-counter birth control and ...

Zetagen Therapeutics announces first patients enrolled in phase 2a clinical study of ZetaMet (Zeta-BC-003) for metastatic ...

FDA rule requires mammogram reports to include breast density info, crucial for detecting cancer in dense breasts.